These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 37341672)

  • 1. Adverse Events and Complications Associated With Vagal Nerve Stimulation: An Analysis of the Manufacturer And User Facility Device Experience Database.
    Lim YG; Ker JRX; Tan YL; Chan DWS; Low DCY; Ng WH; Wan KR
    Neuromodulation; 2024 Jun; 27(4):781-788. PubMed ID: 37341672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vagal Nerve Stimulator Malfunction with Change in Neck Position: Case Report and Literature Review.
    D'Agostino E; Makler V; Bauer DF
    World Neurosurg; 2018 Jun; 114():165-167. PubMed ID: 29555606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterizing the safety profile of vagus nerve stimulation devices for epilepsy from 21,448 manufacturer and user reports.
    Yang VB; Yang AB; Menta AK; Zhao X; Blum J; Madsen JR; Anderson WS
    J Neurosurg; 2024 Jun; ():1-15. PubMed ID: 38875724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complications associated with deep brain stimulation for Parkinson's disease: a MAUDE study.
    Ward M; Ahmed M; Markosian C; Ezike JZ; Agrawal R; Randhawa K; Liang Z; Abraham M; Paskhover B; Mammis A
    Br J Neurosurg; 2021 Oct; 35(5):625-628. PubMed ID: 34151665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laryngology Outcomes Following Implantable Vagus Nerve Stimulation.
    Brauer PR; Lamarre ED; Gau VL; Lorenz RR; Wu SS; Bryson PC
    JAMA Otolaryngol Head Neck Surg; 2023 Jan; 149(1):49-53. PubMed ID: 36416861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An economic evaluation of vagus nerve stimulation as an adjunctive treatment to anti-seizure medications for the treatment of drug resistant epilepsy in the United States.
    Raspin C; Faught E; Armand J; Barion F; Pollit V; Murphy J; Danielson V
    J Med Econ; 2023; 26(1):189-199. PubMed ID: 36691763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigating Complications Associated With Occipital Nerve Stimulation: A MAUDE Study.
    Doran J; Ward M; Ward B; Paskhover B; Umanoff M; Mammis A
    Neuromodulation; 2018 Apr; 21(3):296-301. PubMed ID: 29345415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Device-related complications during renal cryoablation: insights from the Manufacturer and User Facility Device Experience (MAUDE) database.
    Kotamarti S; Michael Z; Silver D; Teper E; Aminsharifi A; Polascik TJ; Schulman A
    Urol Oncol; 2022 May; 40(5):199.e9-199.e14. PubMed ID: 35379535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of Death in US Food and Drug Administration Medical Device Adverse Event Reports in Categories Other Than Death.
    Lalani C; Kunwar EM; Kinard M; Dhruva SS; Redberg RF
    JAMA Intern Med; 2021 Sep; 181(9):1217-1223. PubMed ID: 34309624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes of closed-loop vagal nerve stimulation in patients with refractory epilepsy.
    Tzadok M; Harush A; Nissenkorn A; Zauberman Y; Feldman Z; Ben-Zeev B
    Seizure; 2019 Oct; 71():140-144. PubMed ID: 31326720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adverse Effects and Surgical Complications in Pediatric Patients Undergoing Vagal Nerve Stimulation for Drug-Resistant Epilepsy.
    Trezza A; Landi A; Grioni D; Pirillo D; Fiori L; Giussani C; Sganzerla EP
    Acta Neurochir Suppl; 2017; 124():43-47. PubMed ID: 28120051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complications and safety of vagus nerve stimulation: 25 years of experience at a single center.
    Révész D; Rydenhag B; Ben-Menachem E
    J Neurosurg Pediatr; 2016 Jul; 18(1):97-104. PubMed ID: 27015521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salvage therapy for vagal nerve stimulator infection; Literature review and report of a delayed recurrence.
    Faraj CA; Alok K; Hasbini DA; Najjar MW
    Clin Neurol Neurosurg; 2021 Jan; 200():106333. PubMed ID: 33203592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Learnings from 30 years of reported efficacy and safety of vagus nerve stimulation (VNS) for epilepsy treatment: A critical review.
    Toffa DH; Touma L; El Meskine T; Bouthillier A; Nguyen DK
    Seizure; 2020 Dec; 83():104-123. PubMed ID: 33120323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of VNS therapy with AspireSR
    Hamilton P; Soryal I; Dhahri P; Wimalachandra W; Leat A; Hughes D; Toghill N; Hodson J; Sawlani V; Hayton T; Samarasekera S; Bagary M; McCorry D; Chelvarajah R
    Seizure; 2018 May; 58():120-126. PubMed ID: 29702409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional seizure reduction by replacement with Vagus Nerve Stimulation Model 106 (AspireSR).
    Kawaji H; Yamamoto T; Fujimoto A; Uchida D; Ichikawa N; Yamazoe T; Okanishi T; Sato K; Nishimura M; Tanaka T; Namba H
    Neurosci Lett; 2020 Jan; 716():134636. PubMed ID: 31751671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate Effects of Vagal Nerve Stimulation in Drug-Resistant Epilepsy Revealed by Magnetoencephalographic Recordings.
    Li Y; Zhu H; Chen Q; Yang L; Chen F; Ma H; Xu H; Chen K; Bu J; Zhang R
    Brain Connect; 2023 Feb; 13(1):51-59. PubMed ID: 35974665
    [No Abstract]   [Full Text] [Related]  

  • 18. Revision of vagal nerve stimulation (VNS) electrodes: review and report on use of ultra-sharp monopolar tip.
    Ng WH; Donner E; Go C; Abou-Hamden A; Rutka JT
    Childs Nerv Syst; 2010 Aug; 26(8):1081-4. PubMed ID: 20225085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantation of a new Vagus Nerve Stimulation (VNS) Therapy® generator, AspireSR®: considerations and recommendations during implantation and replacement surgery--comparison to a traditional system.
    Schneider UC; Bohlmann K; Vajkoczy P; Straub HB
    Acta Neurochir (Wien); 2015 Apr; 157(4):721-8. PubMed ID: 25673257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vagal Nerve Stimulation for Drug-Resistant Epilepsy: Adverse Events and Outcome in a Series of Patients with Long-Term Follow-Up.
    Morace R; Di Gennaro G; Quarato PP; D'Aniello A; Mascia A; Grammaldo L; De Risi M; Sparano A; Di Cola F; De Angelis M; Esposito V
    Acta Neurochir Suppl; 2017; 124():49-52. PubMed ID: 28120052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.